Tectonic Therapeutic, Inc.
TECX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $41,364 | $36,966 | $25,654 | $10,977 |
| G&A Expenses | $16,651 | $7,682 | $7,176 | $4,633 |
| SG&A Expenses | $16,651 | $7,682 | $7,176 | $4,633 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $58,015 | $44,648 | $32,830 | $15,610 |
| Operating Income | -$58,015 | -$44,648 | -$32,830 | -$15,610 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $33 | $1,825 | $650 | $6,683 |
| Pre-Tax Income | -$57,982 | -$42,823 | -$32,180 | -$8,927 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$57,982 | -$42,823 | -$32,180 | -$8,927 |
| % Margin | – | – | – | – |
| EPS | -3.93 | -11.59 | -29.05 | -33.36 |
| % Growth | 66.1% | 60.1% | 12.9% | – |
| EPS Diluted | -3.93 | -11.53 | -29.05 | -33.36 |
| Weighted Avg Shares Out | 14,769 | 3,694 | 3,645 | 3,571 |
| Weighted Avg Shares Out Dil | 14,769 | 3,714 | 3,645 | 3,571 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,261 | $581 | $149 | $0 |
| Interest Expense | $107 | $152 | $144 | $224 |
| Depreciation & Amortization | $1,645 | $1,478 | $1,006 | $364 |
| EBITDA | -$56,230 | -$41,193 | -$31,030 | -$8,118 |
| % Margin | – | – | – | – |